These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38972323)

  • 1. Applying the EU regulatory framework for the clinical use of psychedelics.
    Butlen-Ducuing F; Silva F; Silva I; Balabanov P; Thirstrup S
    Lancet Psychiatry; 2024 Jul; ():. PubMed ID: 38972323
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.
    Cruzat J; Perl YS; Escrichs A; Vohryzek J; Timmermann C; Roseman L; Luppi AI; Ibañez A; Nutt D; Carhart-Harris R; Tagliazucchi E; Deco G; Kringelbach ML
    Netw Neurosci; 2022; 6(4):1104-1124. PubMed ID: 38800462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelics in the treatment of unipolar and bipolar depression.
    Bosch OG; Halm S; Seifritz E
    Int J Bipolar Disord; 2022 Jul; 10(1):18. PubMed ID: 35788817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.
    Yu Z; Burback L; Winkler O; Xu L; Dennett L; Vermetten E; Greenshaw A; Li XM; Milne M; Wang F; Cao B; Winship IR; Zhang Y; Chan AW
    Front Psychiatry; 2024; 15():1386321. PubMed ID: 38807690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?
    Andrews CM; Hall W; Humphreys K; Marsden J
    Addiction; 2024 Jun; ():. PubMed ID: 38845381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bio-Psycho-Spiritual Perspectives on Psychedelics: Clinical and Ethical Implications.
    Neitzke-Spruill L; Devenot N; Sisti D; Averill LA; McGuire AL
    Perspect Biol Med; 2024; 67(1):117-142. PubMed ID: 38662068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review.
    Zhornitsky S; Oliva HNP; Jayne LA; Allsop ASA; Kaye AP; Potenza MN; Angarita GA
    Front Psychiatry; 2023; 14():1197890. PubMed ID: 37435405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis.
    Dourron HM; Strauss C; Hendricks PS
    Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis.
    Basedow LA; Majić T; Hafiz NJ; Algharably EAE; Kreutz R; Riemer TG
    Sci Rep; 2024 Jun; 14(1):14782. PubMed ID: 38926480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans.
    Heal DJ; Gosden J; Smith SL
    Neuropharmacology; 2018 Nov; 142():89-115. PubMed ID: 29427652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stutterers' experiences on classic psychedelics: A preliminary self-report study.
    Jackson ES; Goldway N; Gerlach-Houck H; Gold ND
    J Fluency Disord; 2024 May; 81():106062. PubMed ID: 38833909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.
    Kurtz JS; Patel NA; Gendreau JL; Yang C; Brown N; Bui N; Picton B; Harris M; Hatter M; Beyer R; Sahyouni R; Diaz-Aguilar LD; Castellanos J; Schuster N; Abraham ME
    Cureus; 2022 Sep; 14(9):e29167. PubMed ID: 36259015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beating pain with psychedelics: Matter over mind?
    Elman I; Pustilnik A; Borsook D
    Neurosci Biobehav Rev; 2022 Mar; 134():104482. PubMed ID: 34922987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.
    de Vos CMH; Mason NL; Kuypers KPC
    Front Psychiatry; 2021; 12():724606. PubMed ID: 34566723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural Geometrodynamics, Complexity, and Plasticity: A Psychedelics Perspective.
    Ruffini G; Lopez-Sola E; Vohryzek J; Sanchez-Todo R
    Entropy (Basel); 2024 Jan; 26(1):. PubMed ID: 38275498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.
    Atiq MA; Baker MR; Voort JLV; Vargas MV; Choi DS
    Psychopharmacology (Berl); 2024 May; ():. PubMed ID: 38743110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of European psychiatrists on psychedelics: a qualitative study.
    Žuljević MF; Breški N; Kaliterna M; Hren D
    Front Psychiatry; 2024; 15():1411234. PubMed ID: 38855648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.
    Song-Smith C; Jacobs E; Rucker J; Saint M; Cooke J; Schlosser M
    BMJ Open; 2024 Mar; 14(3):e083595. PubMed ID: 38485474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
    Kucsera A; Suppes T; Haug NA
    Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.